medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2013, Number 608

<< Back Next >>

Rev Med Cos Cen 2013; 70 (608)

Encefalopatía hepática

Tinoco MEF

Language: Spanish
References: 12
Page: 563-567
PDF size: 203.07 Kb.


ABSTRACT

Hepathic encephalopathy is a neuropsychiatric disorder secondary to hepatic disfunction in which many biochemical mechanisms are involved. Symptoms can be varied, ranged from an altered mood to coma and death. Diagnosis is mainly clinical, other studies are complementary or to rule out other causes. Correction of precipitating factors along with lowering ammonia therapy remains at the cornerstone of treatment.


REFERENCES

  1. Bass, N. M. et al. Rifaximin treatment in hepatic encephalopathy. N. Engl. J. Med. 362, 1071–1081 (2010)

  2. Bismuth M, Funakoshi N, Cadranel J, P Blanc. Hepatic encephalopathy: from pathophysiology to therapeutic management. European Journal of Gastroenterology & Hepatology 2011; 23:8–22.

  3. Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemicencephalopathy. World journal Gastroenteroly 2013; 19(1): 26-34.

  4. Conn HO. Assessment of mental state. En: Conn HO, editor. The hepatic coma syndromes and lactulose.1 edition. Baltimore. Williams & Wilkins: 1978; 169-188.

  5. Córdoba J. New Assesment of Hepatic Encephalopaty. Journal of Hepatology 2011 vol. 54; 1030– 1040.

  6. Eroglu Y, Byrne WJ. Hepatic Encephalopathy. Emerg Med Clin N Am 27 (2009); 401–414.

  7. Farreras P, Rozman C. Medicina Interna: Vol. 1: 17 ª Ed. Barcelona, España: Elsevier; 2012: 290 - 293.

  8. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716–21.

  9. Harris MK, Elliott D, et al. Neurologic Presentations of Hepatic Disease. Neurol Clin 28 (2010); 89–105.

  10. Jiang Q, Jiang XH, Zheng MH, et al. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a metaanalysis. European Journal of Gastroenterology & Hepatology 2008; 20: 1064–1070.

  11. Schulz G, Ligocki AC, Uili JC. The role of nutrition in hepatic encephalopathy. Current Opinion in Clinical Nutrition and Metabolic Care 2008; 11:275–280.

  12. Sharma P, Sharma BC, Kumar S. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2010; 22: 526–531.




2020     |     www.medigraphic.com